Browse > Article
http://dx.doi.org/10.4196/kjpp.2019.23.6.467

Influence of clozapine on neurodevelopmental protein expression and behavioral patterns in animal model of psychiatric disorder induced by low-level of lead  

Lee, Hwayoung (Department of Clinical Pharmacology, College of Medicine, Soonchunhyang University)
Lee, Minyoung (Department of Clinical Pharmacology, College of Medicine, Soonchunhyang University)
Kim, Hyung-Ki (Department of Clinical Pharmacology, College of Medicine, Soonchunhyang University)
Kim, Young Ock (Department of Bio-Environmental Chemistry, College of Agriculture and Life Sciences, Chungnam National University)
Kwon, Jun-Tack (Department of Clinical Pharmacology, College of Medicine, Soonchunhyang University)
Kim, Hak-Jae (Department of Clinical Pharmacology, College of Medicine, Soonchunhyang University)
Publication Information
The Korean Journal of Physiology and Pharmacology / v.23, no.6, 2019 , pp. 467-474 More about this Journal
Abstract
Exposure to lead during pregnancy is a risk factor for the development of psychiatric disorders in the offspring. In this study, we investigated whether exposure to low levels of lead acetate (0.2%) in drinking water during pregnancy and lactation causes behavioral impairment and affects the expression of proteins associated with neurodevelopment. Lead exposure altered several parameters in rat offspring compared with those unexposed in open-field, social interaction, and pre-pulse inhibition tests. These parameters were restored to normal levels after clozapine treatment. Western blot and immunohistochemical analyses of the hippocampus revealed that several neurodevelopmental proteins were downregulated in lead-exposed rats. The expression was normalized after clozapine treatment (5 mg/kg/day, postnatal day 35-56). These findings demonstrate that downregulation of several proteins in lead-exposed rats affected subsequent behavioral changes. Our results suggest that lead exposure in early life may induce psychiatric disorders and treatment with antipsychotics such as clozapine may reduce their incidence.
Keywords
Animal model; Behavior rating scale; Clozapine; Lead poisoning; Neurodevelopmental disorder;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Liu JT, Chen BY, Zhang JQ, Kuang F, Chen LW. Lead exposure induced microgliosis and astrogliosis in hippocampus of young mice potentially by triggering TLR4-MyD88-$NF{\kappa}B$ signaling cascades. Toxicol Lett. 2015;239:97-107.   DOI
2 Guilarte TR, Opler M, Pletnikov M. Is lead exposure in early life an environmental risk factor for Schizophrenia? neurobiological connections and testable hypotheses. Neurotoxicology. 2012;33:560-574.   DOI
3 Moreira EG, Vassilieff I, Vassilieff VS. Developmental lead exposure: behavioral alterations in the short and long term. Neurotoxicol Teratol. 2001;23:489-495.   DOI
4 Needleman HL, Gunnoe C, Leviton A, Reed R, Peresie H, Maher C, Barrett P. Deficits in psychologic and classroom performance of children with elevated dentine lead levels. N Engl J Med. 1979;300:689-695.   DOI
5 Dietrich KN, Berger OG, Bhattacharya A. Symptomatic lead poisoning in infancy: a prospective case analysis. J Pediatr. 2000;137:568-571.   DOI
6 Kaneshiro Olympio KP. Goncalves C, Risso Gunther WM, Henriques Bechara EJ. Neurotoxicity and aggressiveness triggered by low-level lead in children: a review. Rev Panam Salud Publica/Pan Am J Public Health. 2009;26:266-275.
7 Hu H, Tellez-Rojo MM, Bellinger D, Smith D, Ettinger AS, Lamadrid-Figueroa H, Schwartz J, Schnaas L, Mercado-Garcia A, Hernandez-Avila M. Fetal lead exposure at each stage of pregnancy as a predictor of infant mental development. Environ Health Perspect. 2006;114:1730-1735.   DOI
8 Budtz-Jorgensen E, Bellinger D, Lanphear B, Grandjean P; International Pooled Lead Study Investigators. An international pooled analysis for obtaining a benchmark dose for environmental lead exposure in children. Risk Anal. 2013;33:450-461.   DOI
9 Boksa P. Animal models of obstetric complications in relation to schizophrenia. Brain Res Brain Res Rev. 2004;45:1-17.   DOI
10 Kvajo M, McKellar H, Gogos JA. Avoiding mouse traps in schizophrenia genetics: lessons and promises from current and emerging mouse models. Neuroscience. 2012;211:136-164.   DOI
11 White LD, Cory-Slechta DA, Gilbert ME, Tiffany-Castiglioni E, Zawia NH, Virgolini M, Rossi-George A, Lasley SM, Qian YC, Basha MR. New and evolving concepts in the neurotoxicology of lead. Toxicol Appl Pharmacol. 2007;225:1-27.   DOI
12 Lasley SM, Gilbert ME. Glutamatergic components underlying leadinduced impairments in hippocampal synaptic plasticity. Neurotoxicology. 2000;21:1057-1068.
13 Braff D, Stone C, Callaway E, Geyer M, Glick I, Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 1978;15:339-343.   DOI
14 Brini M, Cali T, Ottolini D, Carafoli E. Neuronal calcium signaling: function and dysfunction. Cell Mol Life Sci. 2014;71:2787-2814.   DOI
15 Rao Barkur R, Bairy LK. Evaluation of passive avoidance learning and spatial memory in rats exposed to low levels of lead during specific periods of early brain development. Int J Occup Med Environ Health. 2015;28:533-544.   DOI
16 Lanphear BP, Dietrich K, Auinger P, Cox C. Cognitive deficits associated with blood lead concentrations <10 microg/dL in US children and adolescents. Public Health Rep. 2000;115:521-529.   DOI
17 Braff DL, Grillon C, Geyer MA. Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry. 1992; 49:206-215.   DOI
18 Geyer MA. The family of sensorimotor gating disorders: comorbidities or diagnostic overlaps? Neurotox Res. 2006;10:211-220.   DOI
19 Pouzet B, Andersen MP, Hogg S. Effects of acute treatment with antidepressant drugs on sensorimotor gating deficits in rats. Psychopharmacology (Berl). 2005;178:9-16.   DOI
20 Khan AH, Zaidi S. Clozapine: improvement of negative symptoms of schizophrenia. Cureus. 2017;9:e1973.   DOI
21 Taya S, Shinoda T, Tsuboi D, Asaki J, Nagai K, Hikita T, Kuroda S, Kuroda K, Shimizu M, Hirotsune S, Iwamatsu A, Kaibuchi K. DISC1 Regulates the Transport of the NUDEL/LIS1/14-3-$3{\varepsilon}$ Complex through Kinesin-1. J Neurosci. 2000;27:15-26.   DOI
22 Won HS, Kim YO, Lee HY, Im JY, Lee SH, Cho IH, Lee SW, Park CG, Kim HK, Kwon JT, Kim HJ. Effect of valeriana fauriei extract on the neurodevelopmental proteins expression and behavioral patterns in maternal immune activation animal model. Korean J Med Crop Sci. 2016;24:341-350.   DOI
23 O'Shea PJ, Harvey CB, Suzuki H, Kaneshige M, Kaneshige K, Cheng SY, Williams GR. A thyrotoxic skeletal phenotype of advanced bone formation in mice with resistance to thyroid hormone. Mol Endocrinol. 2003;17:1410-1424.   DOI
24 Bradshaw NJ, Porteous DJ. DISC1-binding proteins in neural development, signalling and schizophrenia. Neuropharmacology. 2012;62:1230-1241.   DOI
25 Soares DC, Carlyle BC, Bradshaw NJ, Porteous DJ. DISC1: Structure, Function, and Therapeutic Potential for Major Mental Illness. ACS Chem Neurosci. 2011;2:609-632.   DOI
26 Shinoda T, Taya S, Tsuboi D, Hikita T, Matsuzawa R, Kuroda S, Iwamatsu A, bKaibuchi K. DISC1 regulates neurotrophin-induced axon elongation via interaction with Grb2. J Neurosci. 2007;27:4-14.   DOI
27 Institute of Laboratory Animal Resources (Estats Units d'America). Guide for the care and use of laboratory animals. Washington: National Academy Press; 1996. p. xii-125.
28 Le Pen G, Moreau JL. Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacology. 2002;27:1-11.   DOI
29 Lee H, Won H, Im J, Kim YO, Lee S, Cho IH, Kim HK, Kwon JT, Kim HJ. Effect of Valeriana fauriei extract on the offspring of adult rats exposed to prenatal stress. Int J Mol Med. 2016;38:251-258.   DOI
30 Schroeder M, Sultany T, Weller A. Prenatal stress effects on emotion regulation differ by genotype and sex in prepubertal rats. Dev Psychobiol. 2013;55:176-192.   DOI
31 Jung HY, Chung TH, Hwang IK. Dendropanax morbifera Leveille extract ameliorates memory impairments and inflammatory responses in the hippocampus of streptozotocin-induced type 1 diabetic rats. Mol Cell Toxicol. 2016;12:429-436.   DOI
32 Altmann L, Weinsberg F, Sveinsson K, Lilienthal H, Wiegand H, Winneke G. Impairment of long-term potentiation and learning following chronic lead exposure. Toxicol Lett. 1993;66:105-112.   DOI
33 Chen HH, Ma T, Paul IA, Spencer JL, Ho IK. Developmental lead exposure and two-way active avoidance training alter the distribution of protein kinase C activity in the rat hippocampus. Neurochem Res. 1997;22:1119-1125.   DOI
34 Ma T, Chen HH, Ho IK. Effects of chronic lead (Pb) exposure on neurobehavioral function and dopaminergic neurotransmitter receptors in rats. Toxicol Lett. 1999;105:111-121.   DOI
35 Commissaris RL, Tavakoli-Nezhad M, Barron AJ, Pitts DK. Effects of chronic low-level oral lead exposure on prepulse inhibition of acoustic startle in the rat. Neurotoxicol Teratol. 2000;22:55-60.   DOI
36 Vollenweider FX, Barro M, Csomor PA, Feldon J. Clozapine enhances prepulse inhibition in healthy humans with low but not with high prepulse inhibition levels. Biol Psychiatry. 2006;60:597-603.   DOI
37 Kumari V, Soni W, Sharma T. Normalization of information processing deficits in schizophrenia with clozapine. Am J Psychiatry. 1999;156:1046-1051.
38 Hossain S, Bhowmick S, Jahan S, Rozario L, Sarkar M, Islam S, Basunia MA, Rahman A, Choudhury BK, Shahjalal H. Maternal lead exposure decreases the levels of brain development and cognitionrelated proteins with concomitant upsurges of oxidative stress, inflammatory response and apoptosis in the offspring rats. Neurotoxicology. 2016;56:150-158.   DOI
39 Xu J, Yan HC, Yang B, Tong LS, Zou YX, Tian Y. Effects of lead exposure on hippocampal metabotropic glutamate receptor subtype 3 and 7 in developmental rats. J Negat Results Biomed. 2009;8:5.   DOI
40 Neal AP, Worley PF, Guilarte TR. Lead exposure during synaptogenesis alters NMDA receptor targeting via NMDA receptor inhibition. Neurotoxicology. 2011;32:281-289.   DOI
41 Yokoyama K, Araki S. Assessment of slow axonal transport in leadexposed rats. Environ Res. 1992;59:440-446.   DOI
42 Joo J, Lee S, Nah SS, Kim YO, Kim DS, Shim SH, Hwangbo Y, Kim HK, Kwon JT, Kim JW, Song HY, Kim HJ. Lasp1 is down-regulated in NMDA receptor antagonist-treated mice and implicated in human schizophrenia susceptibility. J Psychiatr Res. 2013;47:105-112.   DOI
43 Calabrese F, Guidotti G, Molteni R, Racagni G, Mancini M, Riva MA. Stress-induced changes of hippocampal NMDA receptors: modulation by duloxetine treatment. PLoS One. 2012;7:e37916.   DOI
44 Rubio MD, Drummond JB, Meador-Woodruff JH. Glutamate receptor abnormalities in schizophrenia: implications for innovative treatments. Biomol Ther (Seoul). 2012;20:1-18.   DOI
45 Lee H, Joo J, Nah SS, Kim JW, Kim HK, Kwon JT, Lee HY, Kim YO, Kim HJ. Changes in Dpysl2 expression are associated with prenatally stressed rat offspring and susceptibility to schizophrenia in humans. Int J Mol Med. 2015;35:1574-1586.   DOI
46 von Wilmsdorff M, Manthey F, Bouvier ML, Staehlin O, Falkai P, Meisenzahl-Lechner E, Schmitt A, Gebicke-Haerter PJ. Effects of haloperidol and clozapine on synapse-related gene expression in specific brain regions of male rats. Eur Arch Psychiatry Clin Neurosci. 2018;268:555-563.   DOI
47 Sur C, Mallorga PJ, Wittmann M, Jacobson MA, Pascarella D, Williams JB, Brandish PE, Pettibone DJ, Scolnick EM, Conn PJ. Ndesmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl-D-aspartate receptor activity. Proc Natl Acad Sci U S A. 2003;100:13674-13679.   DOI